Vagus Nerve Stimulation Market Growing at a CAGR of 9.63% During 2017 to 2021

News provided by

ReportsnReports

23 Mar, 2017, 07:00 IST

PUNE, India, March 23, 2017 /PRNewswire/ --

ReportsnReports.com adds Global Vagus Nerve Stimulation Market 2017 - 2021, a latest research report. The global vagus nerve stimulation market analyst says one trend in market is shift of surgeons focus toward minimally invasive VNS procedures. Few years ago, VNS procedures were not popular or limited to few developed countries having high standards of healthcare infrastructure.

Browse 30 Exhibits, 3 Major Company Profiles, spread across 36 pages available at http://www.reportsnreports.com/reports/917298-global-vagus-nerve-stimulation-market-2017-2021.html.

But now, global exposure and availability of many innovative techniques for learning have increased the knowledge of surgeons about VNS devices. Increased communication among the medical fraternity across countries through various media like medical conferences and industrial exhibitions have made the surgeons receive updates about VNS devices In the Americas, countries like the US and Canada have listed surgeries involving VNS devices in revenue generating category. The patients having resistance toward anti-epileptic drugs are being treated with VNS devices. Simultaneously, the focus of surgeons is increasing to minimize the side effects observed while using these devices.

The following companies are the key players in the global vagus nerve stimulation market: LivaNova, Enteromedics, and ElectroCore. Other prominent vendors in the market are: Beijing Medical Equipment and BioControl Medica. Order a copy of Global Vagus Nerve Stimulation Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=917298.

According to the vagus nerve stimulation market report, one driver in market is favorable reimbursement and insurance approval policies. For any device to penetrate the market and later to sustain, depends on various factors, such as, positive results on using the device, user-friendliness, and cost of the device, low side effects, and favorable reimbursement policies. In case of VNS devices, most of the conditions are fulfilled, though some variations are observed based on the type of device. The market growth is expected to increase mainly due to the favorable reimbursement, leading to an increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications. As per the Centers for Medicare & Medicaid Services (CMS) coverage database, spinal cord stimulators are covered under reimbursement when criteria are met.

Global Vagus Nerve Stimulation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global vagus nerve stimulation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomics biomarkers.

Related Reports:    

Explore more reports on Medical Devices at http://www.reportsnreports.com/market-research/medical-devices/.

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411013.
Maharashtra, India.
+ 1 888 391 5441
[email protected]

Connect with Us:  

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds:  http: //http://www.reportsnreports.com/feed/l-latestreports.xml